Oakland, CA, United States of America

Charles A McWherter

This inventor holds 33 USPTO granted patents and 16 published patent applications, primarily in Gastrointestinal Treatments. Top assignees: Cymabay Therapeutics, Inc., Diatex, Inc., Metabolex, Inc.. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A McWherter. Retrieved from https://idiyas.com/inventor/charles-a-mcwherter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 75.8

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 119(Granted Patents)


Location History:

  • San Mateo, CA (US) (2014)
  • Hayward, CA (US) (2013 - 2018)
  • Newark, CA (US) (2019)
  • Oakland, CA (US) (2015 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Areas of Expertise:
NAFLD
NASH
Hyperuricemia
Gout
Cholestatic Diseases
Inflammatory Conditions
Oxymethylene Aryl Compounds
Therapeutic Compositions
GPR131 Agonists
Pyrimidine Salts
Tetrazol-1-yl Compounds
Halofenate
33 patents (USPTO):Explore Patents

Title: The Innovative Journey of Charles A. McWherter

Introduction: Charles A. McWherter, based in Oakland, California, is a renowned inventor with an impressive portfolio of 33 patents to his name. His contributions to the field of medicine, particularly in treating liver diseases, highlight his commitment to advancing healthcare through innovative solutions.

Latest Patents: Among his latest patents, McWherter has made significant strides in the treatment of intrahepatic cholestatic diseases. His patents include therapies utilizing seladelpar and MBX-8025, both of which represent promising avenues for alleviating these complex conditions and enhancing patient care.

Career Highlights: McWherter has built a notable career, contributing his expertise to companies such as Cymabay Therapeutics, Inc. and Diatex, Inc. His focus on developing therapeutic solutions has positioned him as a critical player in the pharmaceutical industry, making substantial contributions to drug development.

Collaborations: Throughout his career, McWherter has collaborated with accomplished professionals such as Brian K. Roberts and Pol Boudes. These partnerships have fostered a creative environment that has propelled innovative ideas into practical applications, resulting in impactful advancements in medical treatment.

Conclusion: Charles A. McWherter's dedication to innovation in the healthcare sector has led to numerous patents and significant collaborations. His work continues to inspire future developments, showcasing how inventive minds can shape the future of medicine and improve the quality of life for many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…